Orally-active ice inhibitors for the treatment of inflammatory and autoimmune diseases.

被引：0
|
作者：
Randle, JCR [1 ]
机构：
[1] Vertex Pharmaceut Inc, Cambridge, MA 02319 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2004年 / 228卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
200-MEDI
引用
收藏
页码：U944 / U944
页数：1
相关论文
共 50 条
  • [41] Oral tolerance in the treatment of inflammatory autoimmune diseases
    Wardrop III R.M.
    Whitacre C.C.
    Inflammation Research, 1999, 48 (3) : 106 - 119
  • [42] MEK inhibitors for the treatment of inflammatory diseases
    Marlow, Allison L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [43] FLAP inhibitors for the treatment of inflammatory diseases
    Sampson, Anthony P.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (11) : 1163 - 1172
  • [44] Oral tolerance in the treatment of inflammatory autoimmune diseases
    Wardrop, RM
    Whitacre, CC
    INFLAMMATION RESEARCH, 1999, 48 (03) : 106 - 119
  • [45] Treatment of systemic autoimmune and inflammatory diseases with rituximab
    Bussone, Guillaume
    Hachulla, Eric
    Sibilia, Jean
    Michel, Marc
    Godeau, Bertrand
    Guillevin, Loic
    Mouthon, Luc
    PRESSE MEDICALE, 2009, 38 (05): : 808 - 823
  • [46] SUCCESSFUL TREATMENT OF THE INSULIN-DEPENDENT DIABETIC BB/S RAT WITH ORALLY-ACTIVE INSULIN
    BONE, AJ
    BARLEY, J
    WINWOOD, D
    EKWURIBE, N
    ROSENBURG, N
    RADHAKRISHNAN, B
    DIABETOLOGIA, 1994, 37 : A164 - A164
  • [47] SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis
    Jacobs, Robert T.
    Nare, Bakela
    Wring, Stephen A.
    Orr, Matthew D.
    Chen, Daitao
    Sligar, Jessica M.
    Jenks, Matthew X.
    Noe, Robert A.
    Bowling, Tana S.
    Mercer, Luke T.
    Rewerts, Cindy
    Gaukel, Eric
    Owens, Jennifer
    Parham, Robin
    Randolph, Ryan
    Beaudet, Beth
    Bacchi, Cyrus J.
    Yarlett, Nigel
    Plattner, Jacob J.
    Freund, Yvonne
    Ding, Charles
    Akama, Tsutomu
    Zhang, Y. -K.
    Brun, Reto
    Kaiser, Marcel
    Scandale, Ivan
    Don, Robert
    PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (06)
  • [48] ITRACONAZOLE (R-51211), A NEW ORALLY-ACTIVE TRIAZOLE DERIVATIVE, FOR TREATMENT OF VAGINAL CANDIDOSIS
    PEETERS, F
    VANDERPAS, H
    PROOST, J
    JANSSENS, D
    SNAUWAERT, E
    VANCUTSEM, J
    CAUWENBERGH, G
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1986, 39 (04): : 496 - 504
  • [49] Non-addictive orally-active kappa opioid agonists for the treatment of peripheral pain in rats
    Beck, Tyler C.
    Reichel, Carmela M.
    Helke, Kristi L.
    Bhadsavle, Sanat S.
    Dix, Thomas A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 856
  • [50] Targeting notch signaling as a safe and effective treatment for autoimmune and lymphoproliferative diseases.
    Teachey, David T.
    Seif, Alix
    Hall, Junior
    Ryan, Theresa
    Reid, Gregor
    Chang, Yueh
    Brown, Valerie
    Grupp, Stephan A.
    BLOOD, 2006, 108 (11) : 195A - 195A
12345